- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Oncologist frets about premature decisions based on PET/CT
"We need to be very rigorous about all aspects of imaging: the way FDG-PET is acquired, its analysis, and the structure of the clinical trial in which it is imbedded.
"We need to be very rigorous about all aspects of imaging: the way FDG-PET is acquired, its analysis, and the structure of the clinical trial in which it is imbedded.
"A concern we have in the treatment community is that physicians are already making decisions based on early PET assessments when we are still not clear about the optimal timing, the interpretation, and whether changing therapy (on the basis of imaging findings) affords a benefit over continuing the prior therapy.
"It is really critical not to ask too many questions in these clinical trials. We should take it one step at a time."
-Dr. Sandra Horning, a professor of medicine (oncology) at Stanford University and president of the American Society of Clinical Oncology, speaking at the 2006 Academy of Molecular Imaging meeting in Orlando.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
